ARC and cardiomyopathy: Conversely, genetic ablation of ARC accelerates cardiomyopathy in the setting of ischemia–reperfusion injury.51 Lu et al.31 further revealed that ARC is a transcriptional target of foxo3a in cardiomyocytes.